Tag: neuroendocrine cancer
Lexicon Pharmaceuticals Begins Phase 3 Clinical Trial of Telotristat Etiprate in Patients with Carcinoid Syndrome
Patients with metastatic carcinoid syndrome will have the opportunity to participate in a new Phase 3 clinical trial of Lexicon Pharmaceutical’s telotristat etiprate (LX1032), an oral drug candidate designed to treat carcinoid syndrome by reducing…
READ MORE
Cycling the C&O Canal for Carcinoid
When Diane and Dwight Mikulis cycle the 184 miles of the Chesapeake & Ohio Canal this summer, they will bring greater awareness to the rare cancer that Diane’s mother, Stella Mae Lux Behers, battled for six years after being diagnosed in 1996. Like …
READ MORE
FDA Approves Amendment for PRRT Clinical Trial in Texas
BREAKING NEWS: The Food and Drug Administration (FDA) has just approved the RadioIsotope Therapy of America (RITA) Foundation’s amendment to the Investigational New Drug (IND) protocol for intra-hepatic artery administration of Lu-177 Octreotate…
READ MORE
Monica Grundmann Dedicates Championship Ride to Carcinoid Cancer Awareness
Congratulations to carcinoid cancer survivor Monica Grundmann on winning the OCTRA 25 mi/40 km Competitive Trail Ride in Stormont, Ontario, Canada with her MORAB stallion, Excalibur Legend, on June 10th (check out those zebra striped gloves!!). …
READ MORE
National Carcinoid and NET Patient Conference: Have You Registered?
Have you registered for the national carcinoid and NET patient conference in New Orleans, September 20 – 22? The hotel is over 90% booked and registration is nearing capacity! This is a wonderful opportunity to learn more about carcinoid and …
READ MORE
Run for Hope to Benefit Carcinoid Cancer Research and Education
Get your running shoes ready for the 8th ANNUAL RUN FOR HOPE on Saturday, August 4, 2012. The goal of the run is to raise awareness of carcinoid cancer, provide education, and give hope . . . while raising funds for carcinoid research and education and the …
READ MORE
Twitter Chat on Rare Disease Day to Focus on Carcinoid and NET Cancers
Join us on Rare Disease Day, February 29th, for a Twitter chat about NET (neuroendocrine tumor) cancers with Steven K. Libutti, MD, Director of Montefiore Einstein Center for Cancer Carein New York. The chat will begin at 2 pm, Eastern Time.
Follow @MontefioreNews…
READ MORE
World Cancer Day — February 4
Today, February 4, is World Cancer Day — uniting the world in the fight against cancer by raising awareness, educating the public, and lobbying for change. Together we can reduce the global cancer burden.
World Cancer Day takes place every year …
New Feature for Medical Professionals on Carcinoid Cancer Foundation Website
The Carcinoid Cancer Foundation is pleased to announce that a new feature for the medical community has been added to its website, www.carcinoid.org. The section is entitled Continuing Medical Education (CME). Upcoming events include:
- The Penn
Breaking News: Pancreatic NET Cancer Patient Steve Jobs Steps Down as CEO of Apple
On August 24, 2011, Steve Jobs, CEO of Apple, announced that he was stepping down from his position. In his letter to the Apple Board of Directors and the Apple Community, Mr. Jobs wrote, “I have always said if there ever came a day when I could no longer meet…
READ MORE
